A Single Center Comparison of Obesity Management Medications and Metabolic Bariatric Surgery in Patients with Left Ventricular Assist Device and Obesity
- 18 April 2026
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (6) , 3434-3436
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart FailureJACC, 2025
- Great Debates: Undergoing the Knife versus Pill-Popping—The Comparative Efficacy and Cost-Effectiveness of Bariatric Surgery and GLP-1 Receptor Agonists in the Management of ObesityThe American Surgeon™, 2025
- Obesity, Challenges, and Weight-Loss Strategies for Patients With Ventricular Assist DevicesJACC: Heart Failure, 2024
- The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled TrialsThe American Journal of Clinical Nutrition, 2023
- Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine, 2021
- Bariatric Surgery in Patients with Obesity and Ventricular Assist Devices Considered for Heart Transplantation: Systematic Review and Individual Participant Data Meta-analysisJournal of Cardiac Failure, 2021
- Ventricular Assist Device Implantation and Bariatric Surgery: A Route to Transplantation in Morbidly Obese Patients with End-Stage Heart FailureASAIO Journal, 2020
- Impact of Obesity on Ventricular Assist Device OutcomesJournal of Cardiac Failure, 2020
- Impact of Obesity on Readmission in Patients With Left Ventricular Assist DevicesThe Annals of Thoracic Surgery, 2018
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001